Coronavirus, How to Protect Ourselves

Coronavirus, How to Protect Ourselves

by Jeffrey Dach MD

Corona Virus Has Changed the World as We Know It

The arrival of the corona virus pandemic has changed the world.  Many of these changes are obvious as we practice social distancing, and wear gloves and mask in public. Our routines at the gym, tennis and golf course, workplaces and places of worship are all disrupted, as many of these have closed their doors to prevent large social gatherings which could spread the virus. Many businesses are suffering from the economic slow down and have drastically reduced income.  The markets are undergoing a series of spasmodic gyrations not seen in years.

How to Protect Ourselves From the Corona virus

First of all I would direct you to a very good video by Dr David Price from Weill Cornell Hospital in New York who explains basic measures how to protect ourselves from the coronavirus.

Click Here for video.

1) Always know where your hands are and keep them clean…
2) use Purell hand sanitizer…
3) wash hands …
4) do not touch your face after coming into contact with outside objects such as door handles, shopping carts, gas pump handle, surfaces etc…
5) wear a mask to prevent oneself from touching face. does not need to be a medical mask
6) know your hands are clean. do not touch face. …
7) distance between people..stay away 3-6 from people..reduce the size of your social circle.

Boosting the Immune System with Supplements

Secondly, I would direct you to Dr. David Brownstein’s recommendations for boosting the immune system with supplements to prepare for dending against a viral infection:

Dr. David Brownstein writes:

“At the first sign of any illness, I suggest my patients take:
100,000 U of vitamin A (NOT beta-carotene),
50,000 U of vitamin D3
5-10,000 mg of vitamin C per day for four days.
Pregnant women should not take high doses of vitamins A and D. Vitamin C can be increased to bowel tolerance” end quote Dr. Brownstein.

Iodine: 25-100 mg/day and more if ill. 

Good Hydration !!!!

I would add to this list good hydration. Remember to drink plenty of fluids with your vitamin C while convalescing from any viral illness.

Link to full article on Dr. Brownstein’s Blog

Hydroxychloroquine, Azithromycin (Z-Pack) and ZInc                         

Dr. Zelenko’s Recommendations

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success using Hydroxychloroquine Sulfate, Zinc and Z-Pak

Thirdly I would refer you to Dr. Zelenko’s for his recommendations.  My son, Benjamin lives in New Jersey with his family and knows Dr. Zelenko, a local MD who has successfully treated more than 700 patients for coronavirus with repurposed drugs and supplements.(35-48)

1) Hydroxychloroquine (Plaquenil requires prescription) 200 mg tabs one tab twice a day for 5 days. Plaquenil was originally FDA approved as a treatment for malaria, and commonly used by rheumatologists for autoimmune disease.  Seven million prescriptions for Plaquenil (r) were written in 2017 by US physicians.  Adverse side effects are rare, and usually associated with long term use greater than ten years. (91-93)(35-48)

2) Azithromycin (Z-Pak 250 mg tabs two tabs first day and one tab daily for next four days.)(35-48)

3) Zinc sulfate, gluconate or acetate (lozenges or capsules10-30mg at the vitamin store).  Zinc inhibits viral RNA polymerase. (49-54)(96-101)

The early addition of zinc to the hydroxychloroquine and azithromycin adds significant benefit to the protocol in hospitalized COV-19 patients according to a recent study by Phillip Carlucci at NYU hospital.(98)   Dr. Carlucci studied the hyroxychloroquine/azithromycin protocol with and without added zinc.  The addition of zinc reduced the mortality or transfer to hospice by approxinately 50%., Dr Carlucci writes:

zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU….After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). (98)

Dr. Ivette Lozano   Update 5/9/20 :  Dr. Ivette Lozano speaks at Texas rally about her dramatically successful use of Hydroxychloroquine Sulfate, Zinc and Z-Pak for her COVID-19 virus patients in her Texas medical clinic.

FDA Issues Emergency Use Authorization for Hydroxychloroquine

On March 29, 2020, the FDA issued an Emergency Use Authorization for hydroxychloroquine as treatment for COVID-119.

Mechanism of Drug Action Against Corona Virus

Both Hydroxychloroquine and Azithromycin are autophagy inhibitors which alter the acidity in lysosomes.  The virus uses lysosomes for replication.  By altering acidity in the lysosomes, corona virus replication is prevented.

This is explained in this article:Yang, Naidi, and Han-Ming Shen. “Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.” Int J Biol Sci 16.10 (2020): 1724-1731.

Governors Hall of Infamy – Banning Hydroxychloroquine with Executive Order – Shame on these governors !!!!!

Governor Steve Sisolak (D-NV)

Gov. Gretchen Whitmer (D-MI) (later reversed)

Gov. Cuomo (D-NY)

Ohio Gov Mike DeWine – limits use

This is America where our governors are free to practice medicine without a license, even if they are wrong. These Governors should be promptly voted out of office !!!!

Coronavirus Drug Treatment References Click Here.

Antiviral Herbals

Dr. Stephen Buhner is the world’s expert on antiviral herbals, and in his book, he recommends :

1) Chinese Skullcap (Scutellaria baicalensis)(6-12)

2) Licorice Root Extract (Glycyrrhiza) (13-18)

3) Elderberry Syrup (Sambucus)(19-22)

4) Quercetin (5-7)

For more, see this article on Antiviral Herbals

Intravenous vitamin C for Severe Cases

For those unfortunate enough to develop viral pneumonia and require treatment in the ICU on a ventilator, many of these patients can be saved by intravenous vitamin C.  Intravenous vitamin C is being used in these severe corona virus ventilator patients in New York Hospitals with success. Demand your doctor give your family member I.V. vitamin C in the hospital. It can save a life.(23-34)

Link to article on Dr. Andrew Weber New York Post:

Treating Corona Virus with IV Vitamin C in New York City

============== =========== ============== ========

Corona Virus is NOT Typical ARDS (Adult Respiratory Distress Syndrome)

Ventilators Are the Killing The Corona Virus Patients !!!!

Dr. Carmeron Kyle-Sidell, an ICU specialist and ER doctor in NYC made the observation that patients with corona virus and hypoxia in the ICU do not have typical ARDS.  They have severe hypoxia, with low O2 Sat, yet are talking and responding normally.  Dr Sidell says that in his opinion , placing these patients on ventilators simply because of a low PO2 on pulse oximetry is a mistake and causes more harm.  Dr Sidell says the correct treatment is high flow oxygen by mask or nasal canula without positive pressure mechanical ventilation.  Use of ventilators should be delayed as long as possible.

Dr. Carmeron Kyle-Sidell : You tube presentation can be found here.

In agreement with Dr Kyle-Sidell is Dr. Luciano Gattinoni from Italy: Here is his publication on the topic.

Gattinoni, Luciano, et al. “Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome.” American Journal of Respiratory and Critical Care Medicine ja (2020).

Also in agreement is the Eastern Virginia Medical School, Dr Paul Marik Protocol for ICU Covid-19 patients:  Click Here.

================  ================  ==========

Higher Mortality Rate of 15% for the elderly over age 80, while NO MORTALITY in children under 9.

Elderly Should Avoid Contact with All Possible Asymptomatic Carriers of the virus.  That means everyone, except essential care givers !!!!

While mortality rates under age 70 are quite low, there is a striking increase in mortality from CoVID-19 (coronavirus) for the elderly over the age of 70.  The Chinese Data on Covid-19 Mortality based on age can be found in two references listed below (1-2).  Here are the data charts.

While the elderly over the age of 80 have a high mortality rate of 15%, children under 9 years of age have virtually no deaths from corona virus.  One might then ask why such a dramatic difference in mortality based on age. In my opinion, this increased mortality in the elderly is related to the high prevalence of dysphagia among the elderly.  Over 50 per cent of the elderly have oropharyngeal dysphagia. (3-4)

Dysphagia is trouble swallowing caused by neuromuscular disorders of the esophagus such as stroke and dementia. These elderly people have esophageal in-coordination and in fact are intermittently aspirating during meals. Intermittent aspiration causes aspiration pneumonia.  If the patient has a viral illness, this leads to aspiration of viral particles into the  lungs, and viral pneumonia.  Dysphagia is also associated with nutritional deficits which impair immunity. In 2012, Dr. Sura writes:.

Dysphagia is a prevalent difficulty among aging adults. Though increasing age facilitates subtle physiologic changes in swallow function, age-related diseases are significant factors in the presence and severity of dysphagia. Among elderly diseases and health complications, stroke and dementia reflect high rates of dysphagia. In both conditions, dysphagia is associated with nutritional deficits and increased risk of pneumonia. Recent efforts have suggested that elderly community dwellers are also at risk for dysphagia and associated deficits in nutritional status and increased pneumonia risk.”(3)

According to Dr Clave in 2015, oropharyngeal dysphagia is highly prevalent in the elderly occurring in 50 per cent of the elderly population.

In 2015, Dr. Clavé writes:

“Although oropharyngeal dysphagia is a highly prevalent condition (occurring in up to 50% of elderly people and 50% of patients with neurological conditions) and is associated with aspiration, severe nutritional and respiratory complications and even death, most patients are not diagnosed and do not receive any treatment.” (4)

Elderly and Hypothyroidism, Immune Dysfunction

Thyroid function is important for proper functioning of the immune system.  This is explained in the article: Hypothyroidism and Risk for Infection. Because of the reduced immunity in hypothyroidism, hypothyroidism is an underlying risk factor for increased mortality from any type of infection, including viral infection.  In the elderly, undetected hypothyroidism is quite common.  And, this prevalence of hypothyroidism is another reason the elderly have increased mortality from corona virus infection. (55-64)

Iodine, Selenium and B12 Deficiency

The elderly have increased prevalence of gastric atrophy , and are at greater risk for micro nutrient deficiency involving iodine, B12 and selenium, all involved in immune function.(65-74)

Protecting the Elderly from Corona Virus

These are a few of the many reasons why special precautions should be taken with the elderly to avoid contact with anyone who might be an asymptomatic carrier of the corona virus, influenza virus, respiratory syncytial virus  or any other respiratory virus, for that matter.(75-84)

============= ===================== ===========

Ozone Therapy for Viral Illness

Ozone can be used to clean your swimming pool.  As a matter of fact our pool has an ozone water cleaning system.   Ozone bubbles through the pool, cleaning the water.  You can also clean your blood stream using medical grade ozone which kill viruses on contact.  Medical Ozone Therapy is a form of oxidative therapy and is highly curative for viral illness, including corona virus. However, this modality is completely ignored by mainstream medicine.  The practitioners I know personally using ozone with considerable success for corona virus are:

1) David Brownstein MD
2) Frank Shallenberger MD
3) Robert Rowen MD
4) Howard Robbins DPM in Manhattan NY 
5) Sano Via Wellness Toronto Canada

================ =============== ===========

Protect Yourself from the News Media  Corona Virus Deceptive Reporting

The Reality on the Ground is Vastly Different

Now that you know how to protect yourself from the corona virus. Next you need to learn how to protect yourself from the news media:(85-87)

Click Here for You Tube Video The Corona Virus “War Zone” by Dana Ashlie

Click Here for You Tube Video: Colleen Smith and Elmhurst Hospital in Queens. The Disconnect between the reality on the ground and the news media hype.

Citizen Journalist Visits the Hospital Corona Virus “War Zone”- Waiting Rooms and Tents Are Empty. !!!!  Click Here for Video Link

================= ============== =================

Doctor Says Government Shut Down is Wrong Approach-Mitigation an Containment are Abject Failures- Instead We Need Herd Immunity

I quite agree with Dr Martin Dubravec writing for the the America Association of Physicians and Surgeons.  His point is that the corona virus is just one of many viruses that circulate every year, and shutting down the economy and the country with draconian “shelter in place ” legislation is the  wrong approach by the government and more disastrous than the virus.  Government policies of mitigation and containment are abject failures.   Dr. Martin Dubravec says that the number of deaths are similar to previous influenza viruses over the years, with the increased mortality among the elderly and those with pre-existing conditions.  Younger people below age 65 have a 99.6% recovery rate. With the measures outlines above, this should be 100% recovery rate. Containment policies are failures because this doesn’t prevent the virus from circulating.  Dr. Martin Dubravec suggests stop the shutdown, and let the virus circulate, creating “herd immunity” in the population, same as previous viruses over the years.   Eventually enough people will develop immunity to the virus and it will be over.  Dr Martin Dubravec writes:

“This is why the concept of herd immunity is so important.  With herd immunity, significant amounts of the population will have exposure to the virus and become immune to it.  They are no longer able to spread the virus as their immune systems kill the virus before it has a chance to grow and multiply.  That individual then becomes not a source of viral spread but a source of killing the virus.  The virus has nowhere to go and it disappears.  Public Policy is Making Things Worse… Unfortunately, our so-called public health experts have pushed for containment and mitigation…. Mitigation is the concept that if you slow the spread of the virus, it will blunt the surge of cases and prevent us from overwhelming hospitals with seriously ill patients. Mitigation efforts have included ordering people to stay in their homes, closing non-essential businesses, and restricting where people can go to locally. This has had no impact on the virus nor should it, as these mitigation efforts are incomplete. …Therefore, containment and mitigation are abject failures. They do not help the situation because they are not being practiced! Nor can they be; our borders are thousands of miles long. Our population needs to eat and get medicines and health care. It is completely unrealistic to believe that mitigation efforts can succeed in a country this big. In totalitarian China, a wall was literally built around Wuhan, the epicenter of the epidemic, to contain and mitigate the virus. Unless we want to become a totalitarian state, we can’t do that here. If we can learn anything from this epidemic is that mitigation efforts that destroy our economy were some of the biggest boondoggles every foisted on the American people. Even worse, they aren’t necessary. We have better ways to combat this virus….What can be done to end this epidemic? The answer is herd immunity. Let those who will not die nor become seriously ill from the disease get infected and immune to the disease. Don’t close schools – open them up! Don’t close universities – reopen them! Let those under the age of 65 with no significant health problems go to work. Their risk of death is very close to zero.  quoted from (85)  Coronavirus COVID-19: Public Health Apocalypse or Panic, Hoax, and Anti-American? Martin Dubravec, MD

Update: April 24, 2020
Fatality Rate for Covid-19 About the Same as Influenza:
Estimated Covid-19 infection fatality rate of 0.12-0.2%

Bendavid, Eran, et al. “COVID-19 Antibody Seroprevalence in Santa Clara County, California.” medRxiv (2020).
Prevalence of coronavirus antibodies of 1.5 percent. Likely prevalence ranged from 2.49 to 4.16 percent.
“these prevalence estimates represent a range between 48,000 and 81,000 people infected in Santa Clara County by early April, 50- 85-fold more than the number of confirmed cases.”

“Using these data, the researchers calculated the infection fatality rate, that is, the percent of people infected with the disease who die: “A hundred deaths out of 48,000-81,000 infections corresponds to an infection fatality rate of 0.12-0.2%,” they report.* That’s about the same infection fatality rate the Centers for Disease Control and Prevention (CDC) estimates for seasonal influenza.” end quote

Conclusion: The Corona Virus has changed the world as we know it.  However, armed with relevant knowledge, we can protect ourselves and loved ones from the virus, the deceptive news media hype about it, and the misguided containment policies of the government.  The infection fatality rate is about the same as influenza, which means the draconian shutdown is a colossal mistake.

Update 4/28/20: Two Urgent Care Physicians discuss the new data and the lack of scientific justification for the corona virus lockdown orders.  The video went viral, reaching over 5.46 million views, and sparked debate over recommendations to lift the shelter-in-place order.  This video was censored, i.e. “taken down” by You Tube. Click Here to watch video: Video interview with Dr. Dan Erickson and Dr. Artin Massihi taken down from YouTube.

Update BioRxiv (2020):   “is unlikely to be fortuitous in nature.

“We found 4 insertions in the spike glycoprotein (S) which are unique to the 2019-nCoV and are not present in other coronaviruses. Importantly, amino acid residues in all the 4 inserts have identity or similarity to those in the HIV-1 gp120 or HIV-1 Gag…is unlikely to be fortuitous in nature.” Pradhan, Prashant, et al. “Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag.” BioRxiv (2020).

Update: 5/15/20 Spiked Interview with Knut Wittkowski
‘We could open up again and forget the whole thing’
Epidemiologist Knut Wittkowski on the deadly consequences of lockdown. For 20 years, Wittkowski was the head of Biostatistics, Epidemiology, and Research Design at The Rockefeller University’s Center for Clinical and Translational Science.

Articles with related Interest:

Intravenous Vitamin C Saves Man Dying of Viral Pneumonia

Anti-Viral Herbals

Vitamin D Prevents Viral Influenza

References:

  1. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China CCDC, February 17 2020
  2. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Pdf] – World Health Organization, Feb. 28, 2020
  3. Sura, Livia, et al. “Dysphagia in the elderly: management and nutritional considerations.” Clinical interventions in aging 7 (2012): 287.
  4. Clavé, Pere, and Reza Shaker. “Dysphagia: current reality and scope of the problem.” Nature Reviews Gastroenterology & Hepatology 12.5 (2015): 259.
  5. Wu, Wenjiao, et al. “Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry.” Viruses 8.1 (2016): 6.
  6. Johari, Jefree, et al. “Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus.” International journal of molecular sciences 13.12 (2012): 16785-16795.
  7. Wu, Wenjiao, et al. “Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry.” Viruses 8.1 (2016): 6.
  8. NAGAI, Takayuki, et al. “Antiviral activity of plant flavonoid, 5, 7, 4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses.” Biological and Pharmaceutical Bulletin 18.2 (1995): 295-299.
  9. XU, Shan, et al. “Antiviral Effect and Mechanism of Scutellaria Baicalensis Georgi [J].” Chinese Archives of Traditional Chinese Medicine 7 (2007).
  10. Shi, Hengfei, et al. “Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.” Scientific reports 6 (2016): 35851.
  11. Nagai, Takayuki, et al. “Mode of action of the anti-influenza virus activity of plant flavonoid, 5, 7, 4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis.” Antiviral research 26.1 (1995): 11-25.
  12. Ding, Yue, et al. “Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.” Archives of virology 159.12 (2014): 3269-3278.
  13. Fiore, Cristina, et al. “Antiviral effects of Glycyrrhiza species.” Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives 22.2 (2008): 141-148.
  14. Wang, Liqiang, et al. “The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb.” Acta Pharmaceutica Sinica B 5.4 (2015): 310-315.
  15. Hamed, Manal Mortady, et al. “Isolation of some chemical constituents from licorice and their evaluation as anticancer and antiviral agents.” Pharmacology online 3 (2013): 95-109.
  16. Mamedov, Nazim A., and Dilfuza Egamberdieva. “Phytochemical constituents and pharmacological effects of licorice: a review.” Plant and Human Health, Volume 3. Springer, Cham, 2019. 1-21.
  17. Yasmin, A. R., et al. “Herbal extracts as antiviral agents.” Feed Additives. Academic Press, 2020. 115-132.
  18. Sun, Zhi-Gang, et al. “Research Progress of Glycyrrhizic Acid on Antiviral Activity.” Mini reviews in medicinal chemistry 19.10 (2019): 826-832.
  19. Torabian, Golnoosh, et al. “Anti-influenza activity of elderberry (Sambucus nigra).” Journal of functional foods 54 (2019): 353-360.
  20. Cock, Ian Edwin. “Elderberry Compounds Inhibit Cellular Entry of Influenza Virus, Thereby Decreasing Infectivity and Decreasing Flu Symptoms.” Pharmacognosy Communications 9.4 (2019): 151-151.
  21. Weng, Jing-Ru, et al. “Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63.” Virus Research 273 (2019): 197767.
  22. Krawitz, Christian, et al. “Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses.” BMC complementary and alternative medicine 11.1 (2011): 16.
  23. Kim, Yejin, et al. “Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-α/β at the initial stage of influenza A virus (H3N2) infection.” Immune network 13.2 (2013): 70-74.
  24. Colunga Biancatelli, Ruben Manuel Luciano, Max Berrill, and Paul E. Marik. “The antiviral properties of vitamin C.” (2020).
  25. Marik, Paul E., et al. “Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study.” Chest 151.6 (2017): 1229-1238.
  26. Moskowitz, Ari, et al. “Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation.” Critical Care 22.1 (2018): 283.
  27. Marik, Paul E. “Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid.” Nutrients 10.11 (2018): 1762.
  28. Balakrishnan, Mahesh, et al. “Hydrocortisone, vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery.” Indian journal of anaesthesia 62.12 (2018): 934.
  29. Litwak, Jane J., et al. “Vitamin C, hydrocortisone, and thiamine for the treatment of severe sepsis and septic shock: a retrospective analysis of real-world application.” Journal of clinical medicine 8.4 (2019): 478.
  30. Gurganus, Margot M., Paul E. Marik, and Joseph Varon. “The successful treatment of severe aspiration pneumonitis with the combination of hydrocortisone, ascorbic acid, and thiamine.” Critical Care & Shock 22.1 (2019).
  31. Marik, Paul E. “Vitamin C: an essential “stress hormone” during sepsis.” Journal of Thoracic Disease 12.Suppl 1 (2020): S84.
  32. Shin, Tae Gun, et al. “Early vitamin C and thiamine administration to patients with septic shock in emergency departments: Propensity score-based analysis of a before-and-after cohort study.” Journal of clinical medicine 8.1 (2019): 102.
  33. Amrein, Karin, Heleen M. Oudemans-van Straaten, and Mette M. Berger. “Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D.” Intensive care medicine 44.11 (2018): 1940-1944.
  34. Sewify, Khaled, and A. R. Alshaer. “New sepsis cocktail–thanks for the new marik protocol.” J Anesth Crit Care Open Access 10.2 (2018): 73-74.
  35. Yao, Xueting, et al. “In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).” Clinical Infectious Diseases (2020).
  36. Colson, Philippe, et al. “Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.” Int J Antimicrob Agents 105932 (2020).
  37. Gautret, Philippe, et al. “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.” International Journal of Antimicrobial Agents (2020): 105949.
  38. Liu, Jia, et al. “Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.” Cell Discovery 6.1 (2020): 1-4.
  39. Savarino, Adrea, et al. “Effects of chloroquine on viral infections: an old drug against today’s diseases.” The Lancet infectious diseases 3.11 (2003): 722-727.
  40. Singh, Awadhesh Kumar, et al. “Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.” Diabetes & Metabolic Syndrome: Clinical Research & Reviews (2020).
  41. Gao, Jianjun, Zhenxue Tian, and Xu Yang. “Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.” Bioscience trends (2020).
  42. Kono, Masakazu, et al. “Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.” Antiviral research 77.2 (2008): 150-152.
  43. Sandeep, Samarth, and Kirk McGregor. “Energetics Based Modeling of Hydroxychloroquine and Azithromycin Binding to the SARS-CoV-2 Spike (S) Protein-ACE2 Complex.” (2020).
  44. Kapoor, Krishan Mohan, and Aanandita Kapoor. “Role of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19 Infection-A Systematic Literature Review.” medRxiv (2020).
  45. Rolain, Jean-Marc, Philippe Colson, and Didier Raoult. “Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.” International journal of antimicrobial agents 30.4 (2007): 297-308.
  46. Srivatsan Padmanabhan, M. D. “Potential dual therapeutic approach against SARS-CoV-2/COVID-19 with Nitazoxanide and Hydroxychloroquine.”
  47. Lover, Andrew A. “Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020).” medRxiv (2020).
  48. Savarino, Andrea. “Use of chloroquine in viral diseases.” The Lancet infectious diseases 11.9 (2011): 653-654.
  49. Te Velthuis, Aartjan JW, et al. “Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.” PLoS pathogens 6.11 (2010).
  50. Chai, Weidong, et al. “High-dose dietary zinc oxide mitigates infection with transmissible gastroenteritis virus in piglets.” BMC veterinary research 10.1 (2014): 75.
  51. Wei, Zhanyong, et al. “Antiviral activity of zinc salts against transmissible gastroenteritis virus in vitro.” Veterinary microbiology 160.3-4 (2012): 468-472.
  52. Berg, Kurt, et al. “Zinc potentiates the antiviral action of human IFN-α tenfold.” Journal of Interferon & Cytokine Research 21.7 (2001): 471-474.
  53. MacDonald, Margaret R., et al. “The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses.” Journal of virology 81.24 (2007): 13509-13518.
  54. Ishida, T. “Virucidal activities of zinc-finger antiviral proteins and zinc-binding domains for virus entry.” DNA/RNA replication and spread (2020): 9-13.
  55. De Vito, Paolo, et al. “Thyroid hormones as modulators of immune activities at the cellular level.” Thyroid 21.8 (2011): 879-890.
  56. Perrotta, Cristiana, et al. “The thyroid hormone triiodothyronine controls macrophage maturation and functions: protective role during inflammation.” The American journal of pathology 184.1 (2014): 230-247.
  57. De Vito, Paolo, et al. “Thyroid hormones as modulators of immune activities at the cellular level.” Thyroid 21.8 (2011): 879-890.
  58. Alamino, V. A., et al. “The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity.” OncoImmunology 5.1 (2016): e1064579.
  59. Hodkinson, Clare F., et al. “Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55–70 years.” Journal of Endocrinology 202.1 (2009): 55-63.
  60. Schoenfeld, Philip S., et al. “Suppression of cell-mediated immunity in hypothyroidism.” Southern medical journal 88.3 (1995): 347-349.
  61. Luboshitzky, R., et al. “Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population.” Israel journal of medical sciences 32.1 (1996): 60-65.
  62. Bensenor, Isabela M., Rodrigo D. Olmos, and Paulo A. Lotufo. “Hypothyroidism in the elderly: diagnosis and management.” Clinical interventions in aging 7 (2012): 97.
  63. Benseñor, Isabela M., et al. “Prevalence of thyroid disorders among older people: results from the São Paulo Ageing & Health Study.” Cadernos de saude publica 27 (2011): 155-161.
  64. Saifi, Akhtar, Alireza Ahmadi, and Azadreza Mansourian. “Hypothyroidism in Elderly Population: A Review.” Journal of Clinical and Basic Research 1.1 (2017): 47-53.
  65. Schomburg, Lutz, and Josef Köhrle. “On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health.” Molecular nutrition & food research 52.11 (2008): 1235-1246.
  66. Gilles, A., P. Lebreton, and A. Troegeler-Meynadier. “Effects of a selenium and iodine supplementation of pregnant cow on the newborn calf mineral and immune status.” Revue De Medecine Veterinaire 160.1 (2009): 10-17.
  67. Triggiani, Vincenzo, et al. “Role of iodine, selenium and other micronutrients in thyroid function and disorders.” Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 9.3 (2009): 277-294.
  68. Song, Zhigang, Yuming Guo, and Jianmin Yuan. “Effects of dietary iodine and selenium on the activities of blood lymphocytes in laying hens.” Asian-australasian journal of animal sciences 19.5 (2006): 713-719.
  69. Siddiqui, M. Mohsin. Effects of organic and inorganic iodine supplementation on the performance and immune response of feedlot cattle. Diss. Texas Tech University, 1993.
  70. Erkurt, Mehmet Ali, et al. “Effects of cyanocobalamin on immunity in patients with pernicious anemia.” Medical Principles and Practice 17.2 (2008): 131-135.
  71. Carmel, Ralph. “Cobalamin, the stomach, and aging.” The American journal of clinical nutrition 66.4 (1997): 750-759.
  72. Spinas, Enrico, et al. “Crosstalk between vitamin B and immunity.” J Biol Regul Homeost Agents 29.2 (2015): 283-8.
  73. Kätkä, Kalevi. “Immune functions in pernicious anaemia before and during treatment with vitamin B12.” Scandinavian journal of haematology 32.1 (1984): 76-82.
  74. Wolters, Maike, Alexander Ströhle, and Andreas Hahn. “Cobalamin: a critical vitamin in the elderly.” Preventive medicine 39.6 (2004): 1256-1266.
  75. Rowen, R. J., and H. Robins. “A Plausible “Penny” Costing Effective Treatment for Corona Virus Ozone Therapy.” J Infect Dis Epidemiol 6 (2020): 113.
  76. Rowen, Robert Jay. “Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience.” Medical Gas Research 9.4 (2019): 232.
  77. Sunnen, Gérard V. “Ozone in medicine: overview and future directions.” J Adv Med 1.3 (1988): 15974.
  78. Bolton, David C., Yuan Chung Zee, and John W. Osebold. “The biological effects of ozone on representative members of five groups of animal viruses.” Environmental Research 27.2 (1982): 476-484.
  79. Bocci, Vielio. “Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis.” Medical Hypotheses 39.1 (1992): 30-34.
  80. Murray, Byron K., et al. “Virion disruption by ozone-mediated reactive oxygen species.” Journal of virological methods 153.1 (2008): 74-77.
  81. Elvis, A. M., and J. S. Ekta. “Ozone therapy: A clinical review.” Journal of natural science, biology, and medicine 2.1 (2011): 66.
  82. Friedman, L. I., and R. R. Stromberg. “Viral inactivation and reduction in cellular blood products.” Revue française de transfusion et d’hémobiologie 36.1 (1993): 83-91.
  83. Rowen, Robert Jay. “Ultraviolet blood irradiation therapy (Photo-Oxidation) the cure that time forgot.” Int J. Biosocial Med Research Vol 14.2 (1996): 115-32.
  84. Wu, Ximing, Xiaoqing Hu, and Michael R. Hamblin. “Ultraviolet blood irradiation: Is it time to remember “the cure that time forgot”?.” Journal of Photochemistry and Photobiology B: Biology 157 (2016): 89-96.
  85. Coronavirus COVID-19: Public Health Apocalypse or Panic, Hoax, and Anti-American? Martin Dubravec, MD March 30, 2020
    Allergist/Clinical Immunologist Allergy and Asthma Specialists of Cadillac Cadillac, MI, American Association of Physicians and Surgeons
  86. Perspectives on the Pandemic | Professor Knut Wittkowski | Episode 2 Apr 3, 2020
  87. Facts about Covid-19, Swiss Propaganda Research (SPR), founded in 2016, is an independent nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is run by independent academics and receives no external funding.
  88. Peeples, Lynne. “News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.” Proceedings of the National Academy of Sciences (2020).
  89. Huisman, Willem, et al. “Vaccine-induced enhancement of viral infections.Vaccine 27.4 (2009): 505-512.
  90. Patrì, Angela, and Gabriella Fabbrocini. “Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?.” Journal of the American Academy of Dermatology 82.6 (2020): e221.
  91. Caly, Leon, et al. “The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.” Antiviral Research (2020): 104787.  To test the antiviral activity of ivermectin towards SARS-CoV-2, we infected Vero/hSLAM cells with SARS-CoV-2 isolate Australia/VIC01/2020 at an MOI of 0.1 for 2 h, followed by the addition of 5 μM ivermectin. Supernatant and cell pellets were harvested at days 0-3 and analysed by RT-PCR for the replication of SARS-CoV-2 RNA (Fig. 1A/B). At 24 h, there was a 93% reduction in viral RNA present in the supernatant (indicative of released virions) of samples treated with ivermectin compared to the vehicle DMSO. Similarly a 99.8% reduction in cell-associated viral RNA (indicative of unreleased and unpackaged virions) was observed with ivermectin treatment. By 48h this effect increased to an ∼5000-fold reduction of viral RNA in ivermectin-treated compared to control samples, indicating that ivermectin treatment resulted in the effective loss of essentially all viral material by 48 h.
  92. Bray, Mike, et al. “Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors’ responses.” Antiviral Research (2020).
  93. Keyaerts, Els, et al. “Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice.” Antimicrobial agents and chemotherapy 53.8 (2009): 3416-3421.
  94. Vincent, Martin J., et al. “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.” Virology journal 2.1 (2005): 69.
  95. Keyaerts, Els, et al. “In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.” Biochemical and biophysical research communications 323.1 (2004): 264-268.
  96. Padhan, Kartika, et al. “Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation.” Journal of general virology 89.8 (2008): 1960-1969.
  97. de Wilde, Adriaan H., et al. “Cyclosporin A inhibits the replication of diverse coronaviruses.” The Journal of general virology 92.Pt 11 (2011): 2542.
  98. Te Velthuis, Aartjan JW, et al. “Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.” PLoS pathogens 6.11 (2010).
  99. Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients American College of Physicians and Surgeons April 28.2020.
  100. Carlucci, Philip, et al. “Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients.” medRxiv (2020).Hydroxychloroquine azithromycin plus zinc in hospitalized COVID19 patients Phillip Carlucci 2020
  101. Te Velthuis, Aartjan JW, et al. “Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.” PLoS pathogens 6.11 (2010).
  102. Skalny, Anatoly V., et al. “Zinc and respiratory tract infections: Perspectives for COVID‑19.” International Journal of Molecular Medicine (2020).
  103. Schaper, Charles. “A Mechanism of Action for Hydroxychloroquine and Azithromycin to Inhibit Coronavirus Disease COVID-19.” (2020).
  104. Anderson, George, and Russel J. Reiter. “Melatonin: Roles in influenza, Covid‐19, and other viral infections.” Reviews in Medical Virology (2020): e2109.
  105. Reiter, Russel J., et al. “Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis.” Medicine in Drug Discovery (2020).
  106. Zhang, Rui, et al. “COVID-19: Melatonin as a potential adjuvant treatment.” Life sciences (2020): 117583.
  107. Caly, Leon, et al. “The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.” Antiviral research (2020): 104787.
  108. Varghese, Finny S., et al. “Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.” Antiviral research 126 (2016): 117-124.
  109. Dasgupta, Jhimli, et al. “Nsp7 and Spike Glycoprotein of SARS-CoV-2 are envisaged as Potential Targets of Vitamin D and Ivermectin.” (2020).
  110. Patrì, Angela, and Gabriella Fabbrocini. “Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?.” Journal of the American Academy of Dermatology 82.6 (2020): e221.
  111. Momekov, Georgi, and Denitsa Momekova. “Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view.” medRxiv (2020).
  112. Choudhary, Renuka, and Anil K. Sharma. “Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance.” New Microbes and New Infections (2020): 100684.
  113. Khater, Shradha, and Gautam Das. “Repurposing Ivermectin to inhibit the activity of SARS CoV2 helicase: possible implications for COVID 19 therapeutics.” (2020).
  114. Gassen, Nils C., et al. “Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics.” bioRxiv (2020).
  115. Xu, Jimin, et al. “Broad spectrum antiviral agent niclosamide and its therapeutic potential.” ACS infectious diseases (2020).
  116. Pindiprolu, Sai Kiran SS, and Sai Harshini Pindiprolu. “Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19.” Medical Hypotheses (2020): 109765.
  117. Huang, Lu, et al. “Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.” Antiviral research 138 (2017): 68-78.

Images courtesy of Wikimedia commons in public domain:

Image One

Image Two

Image three

Jeffey Dach MD
7450 Griffin Road, Suite 190
Davie, Fl 33314
954-792-4663
www.jeffreydachmd.com
www.drdach.com
Heart Book by Jeffrey Dach
www.naturalmedicine101.com
www.bioidenticalhormones101.com
www.truemedmd.com

Click Here for: Dr Dach’s Online Store for Pure Encapsulations Supplements
Click Here for: Dr Dach’s Online Store for Nature’s Sunshine Supplements

Web Site and Discussion Board Links:

jdach1.typepad.com/blog/
disc.yourwebapps.com/Indices/244066.html
disc.yourwebapps.com/Indices/244067.html
http://sci.med.narkive.com/covV2Qo2/jeffrey-dach-book-announcment-natural-medicine-101

Disclaimer

The reader is advised to discuss the comments on these pages with his/her personal physicians and to only act upon the advice of his/her personal physician. Also note that concerning an answer which appears as an electronically posted question, I am NOT creating a physician — patient relationship. Although identities will remain confidential as much as possible, as I can not control the media, I can not take responsibility for any breaches of confidentiality that may occur.

Link to this Article

Copyright (c) 2020 Jeffrey Dach MD All Rights Reserved. This article may be reproduced on the internet without permission, provided there is a link to this page and proper credit is given. See Repost Guidelines.

FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

Serving Areas of: Hollywood, Aventura, Miami, Fort Lauderdale, Pembroke Pines, Miramar, Davie, Coral Springs, Cooper City, Sunshine Ranches, Hallandale, Surfside, Miami Beach, Sunny Isles, Normandy Isles, Coral Gables, Hialeah, Golden Beach ,Kendall,sunrise, coral springs, parkland,pompano, boca raton, palm beach, weston, dania beach, tamarac, oakland park, boynton beach, delray,lake worth,wellington,plantation

 

Last updated on by Jeffrey Dach MD

Summary
Coronavirus How to Protect Ourselves
Article Name
Coronavirus How to Protect Ourselves
Description
How to Protect Ourselves from the Corona virus using common sense measures.
Author
publisher
jeffrey dach md
publisher logo

4 thoughts on “Coronavirus, How to Protect Ourselves

  1. March 26 at 12:42 PM
    Repost from another person. Interesting read.

    “I am an ER MD in New Orleans. Class of 98. Every one of my colleagues have now seen several hundred Covid 19 patients and this is what I think I know.

    Clinical course is predictable.
    2-11 days after exposure (day 5 on average) flu like symptoms start. Common are fever, headache, dry cough, myalgias(back pain), nausea without vomiting, abdominal discomfort with some diarrhea, loss of smell, anorexia, fatigue.

    Day 5 of symptoms- increased SOB, and bilateral viral pneumonia from direct viral damage to lung parenchyma.

    Day 10- Cytokine storm leading to acute ARDS and multiorgan failure. You can literally watch it happen in a matter of hours.

    81% mild symptoms, 14% severe symptoms requiring hospitalization, 5% critical.

    Patient presentation is varied. Patients are coming in hypoxic (even 75%) without dyspnea. I have seen Covid patients present with encephalopathy, renal failure from dehydration, DKA. I have seen the bilateral interstitial pneumonia on the xray of the asymptomatic shoulder dislocation or on the CT’s of the (respiratory) asymptomatic polytrauma patient. Essentially if they are in my ER, they have it. Seen three positive flu swabs in 2 weeks and all three had Covid 19 as well. Somehow this ***** has told all other disease processes to get out of town.

    China reported 15% cardiac involvement. I have seen covid 19 patients present with myocarditis, pericarditis, new onset CHF and new onset atrial fibrillation. I still order a troponin, but no cardiologist will treat no matter what the number in a suspected Covid 19 patient. Even our non covid 19 STEMIs at all of our facilities are getting TPA in the ED and rescue PCI at 60 minutes only if TPA fails.

    Diagnostic
    CXR- bilateral interstitial pneumonia (anecdotally starts most often in the RLL so bilateral on CXR is not required). The hypoxia does not correlate with the CXR findings. Their lungs do not sound bad. Keep your stethoscope in your pocket and evaluate with your eyes and pulse ox.

    Labs- WBC low, Lymphocytes low, platelets lower then their normal, Procalcitonin normal in 95%
    CRP and Ferritin elevated most often. CPK, D-Dimer, LDH, Alk Phos/AST/ALT commonly elevated.
    Notice D-Dimer- I would be very careful about CT PE these patients for their hypoxia. The patients receiving IV contrast are going into renal failure and on the vent sooner.

    Basically, if you have a bilateral pneumonia with normal to low WBC, lymphopenia, normal procalcitonin, elevated CRP and ferritin- you have covid-19 and do not need a nasal swab to tell you that.

    A ratio of absolute neutrophil count to absolute lymphocyte count greater than 3.5 may be the highest predictor of poor outcome. the UK is automatically intubating these patients for expected outcomes regardless of their clinical presentation.

    An elevated Interleukin-6 (IL6) is an indicator of their cytokine storm. If this is elevated watch these patients closely with both eyes.

    Other factors that appear to be predictive of poor outcomes are thrombocytopenia and LFTs 5x upper limit of normal.

    Disposition
    I had never discharged multifocal pneumonia before. Now I personally do it 12-15 times a shift. 2 weeks ago we were admitting anyone who needed supplemental oxygen. Now we are discharging with oxygen if the patient is comfortable and oxygenating above 92% on nasal cannula. We have contracted with a company that sends a paramedic to their home twice daily to check on them and record a pulse ox. We know many of these patients will bounce back but if it saves a bed for a day we have accomplished something. Obviously we are fearful some won’t make it back.

    We are a small community hospital. Our 22 bed ICU and now a 4 bed Endoscopy suite are all Covid 19. All of these patients are intubated except one. 75% of our floor beds have been cohorted into covid 19 wards and are full. We are averaging 4 rescue intubations a day on the floor. We now have 9 vented patients in our ER transferred down from the floor after intubation.

    Luckily we are part of a larger hospital group. Our main teaching hospital repurposed space to open 50 new Covid 19 ICU beds this past Sunday so these numbers are with significant decompression. Today those 50 beds are full. They are opening 30 more by Friday. But even with the “lockdown”, our AI models are expecting a 200-400% increase in covid 19 patients by 4/4/2020.

    Treatment
    Supportive

    worldwide 86% of covid 19 patients that go on a vent die. Seattle reporting 70%. Our hospital has had 5 deaths and one patient who was extubated. Extubation happens on day 10 per the Chinese and day 11 per Seattle.

    Plaquenil which has weak ACE2 blockade doesn’t appear to be a savior of any kind in our patient population. Theoretically, it may have some prophylactic properties but so far it is difficult to see the benefit to our hospitalized patients, but we are using it and the studies will tell. With Plaquenil’s potential QT prolongation and liver toxic effects (both particularly problematic in covid 19 patients), I am not longer selectively prescribing this medication as I stated on a previous post.

    We are also using Azithromycin, but are intermittently running out of IV.

    Do not give these patient’s standard sepsis fluid resuscitation. Be very judicious with the fluids as it hastens their respiratory decompensation. Outside the DKA and renal failure dehydration, leave them dry.

    Proning vented patients significantly helps oxygenation. Even self proning the ones on nasal cannula helps.

    Vent settings- Usual ARDS stuff, low volume, permissive hypercapnia, etc. Except for Peep of 5 will not do. Start at 14 and you may go up to 25 if needed.

    Do not use Bipap- it does not work well and is a significant exposure risk with high levels of aerosolized virus to you and your staff. Even after a cough or sneeze this virus can aerosolize up to 3 hours.

    The same goes for nebulizer treatments. Use MDI. you can give 8-10 puffs at one time of an albuterol MDI. Use only if wheezing which isn’t often with covid 19. If you have to give a nebulizer must be in a negative pressure room; and if you can, instruct the patient on how to start it after you leave the room.

    Do not use steroids, it makes this worse. Push out to your urgent cares to stop their usual practice of steroid shots for their URI/bronchitis.

    We are currently out of Versed, Fentanyl, and intermittently Propofol. Get the dosing of Precedex and Nimbex back in your heads.

    One of my colleagues who is a 31 yo old female who graduated residency last may with no health problems and normal BMI is out with the symptoms and an SaO2 of 92%. She will be the first of many.

    I PPE best I have. I do wear a MaxAir PAPR the entire shift. I do not take it off to eat or drink during the shift. I undress in the garage and go straight to the shower. My wife and kids fled to her parents outside Hattiesburg. The stress and exposure at work coupled with the isolation at home is trying. But everyone is going through something right now. Everyone is scared; patients and employees. But we are the leaders of that emergency room. Be nice to your nurses and staff. Show by example how to tackle this crisis head on. Good luck to us all.”

Leave a Reply